SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-394598
Filing Date
2012-09-18
Accepted
2012-09-18 06:07:21
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d366975d10k.htm 10-K 1043729
2 CONSENT OF BDO USA LLP d366975dex231.htm EX-23.1 1880
3 CERTIFICATION d366975dex311.htm EX-31.1 10134
4 CERTIFICATION d366975dex312.htm EX-31.2 10131
5 CERTIFICATION d366975dex321.htm EX-32.1 3346
  Complete submission text file 0001193125-12-394598.txt   6508936

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT meip-20120630.xml EX-101.INS 798156
7 XBRL TAXONOMY EXTENSION SCHEMA meip-20120630.xsd EX-101.SCH 64132
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meip-20120630_cal.xml EX-101.CAL 61174
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meip-20120630_def.xml EX-101.DEF 327672
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20120630_lab.xml EX-101.LAB 494948
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20120630_pre.xml EX-101.PRE 378392
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50484 | Film No.: 121096077
SIC: 2834 Pharmaceutical Preparations